Bio-Rad Laboratories (NYSE:BIO.B) Releases Earnings Results

Bio-Rad Laboratories (NYSE:BIO.B) issued its earnings results on Thursday. The company reported $2.90 earnings per share for the quarter, Zacks reports. Bio-Rad Laboratories had a positive return on equity of 3.74% and a negative net margin of 30.18%.

Bio-Rad Laboratories Trading Down 2.3 %

Shares of BIO.B traded down $7.32 during mid-day trading on Thursday, hitting $312.05. 262 shares of the company’s stock traded hands, compared to its average volume of 280. The company has a quick ratio of 4.52, a current ratio of 6.14 and a debt-to-equity ratio of 0.16. The firm has a market capitalization of $8.74 billion, a P/E ratio of -11.42 and a beta of 0.73. The business’s 50-day moving average price is $338.36 and its 200-day moving average price is $332.90. Bio-Rad Laboratories has a 1 year low of $279.91 and a 1 year high of $359.22.

Bio-Rad Laboratories Company Profile

Bio-Rad Laboratories, Inc manufactures, and distributes life science research and clinical diagnostic products in the United States, Europe, Asia, Canada, and Latin America. The company operates through Life Science and Clinical Diagnostics segments. The Life Science segment develops, manufactures, and markets a range of reagents, apparatus, and laboratory instruments that are used in research techniques, biopharmaceutical production processes, and food testing regimes.